165 related articles for article (PubMed ID: 8783553)
1. Cyclic nucleotide phosphodiesterases: gene complexity, regulation by phosphorylation, and physiological implications.
Burns F; Zhao AZ; Beavo JA
Adv Pharmacol; 1996; 36():29-48. PubMed ID: 8783553
[No Abstract] [Full Text] [Related]
2. Cyclic nucleotides and phosphodiesterases in platelets.
Haslam RJ; Dickinson NT; Jang EK
Thromb Haemost; 1999 Aug; 82(2):412-23. PubMed ID: 10605732
[No Abstract] [Full Text] [Related]
3. Type III cyclic nucleotide phosphodiesterases and insulin action.
Manganiello VC; Degerman E; Taira M; Kono T; Belfrage P
Curr Top Cell Regul; 1996; 34():63-100. PubMed ID: 8646851
[No Abstract] [Full Text] [Related]
4. Recent advances in the study of Ca2+/CaM-activated phosphodiesterases: expression and physiological functions.
Zhao AZ; Yan C; Sonnenburg WK; Beavo JA
Adv Second Messenger Phosphoprotein Res; 1997; 31():237-51. PubMed ID: 9344255
[No Abstract] [Full Text] [Related]
5. Cyclic nucleotide phosphodiesterases and human arterial smooth muscle cell proliferation.
Rybalkin SD; Bornfeldt KE
Thromb Haemost; 1999 Aug; 82(2):424-34. PubMed ID: 10605733
[No Abstract] [Full Text] [Related]
6. Inhibitors of cyclic nucleotide phosphodiesterase 3 and 5 as therapeutic agents in heart failure.
Stehlik J; Movsesian MA
Expert Opin Investig Drugs; 2006 Jul; 15(7):733-42. PubMed ID: 16787138
[TBL] [Abstract][Full Text] [Related]
7. Calmodulin-dependent cyclic nucleotide phosphodiesterase (PDE1).
Kakkar R; Raju RV; Sharma RK
Cell Mol Life Sci; 1999 Jul; 55(8-9):1164-86. PubMed ID: 10442095
[TBL] [Abstract][Full Text] [Related]
8. Multiplicity within cyclic nucleotide phosphodiesterases.
Rybalkin SD; Beavo JA
Biochem Soc Trans; 1996 Nov; 24(4):1005-9. PubMed ID: 8968501
[No Abstract] [Full Text] [Related]
9. Participation of peripheral and spinal phosphodiesterases 4 and 5 in inflammatory pain.
Torres-López JE; Argüelles CF; Granados-Soto V
Proc West Pharmacol Soc; 2002; 45():141-3. PubMed ID: 12434560
[No Abstract] [Full Text] [Related]
10. Characterization of the cyclic nucleotide phosphodiesterase subtypes involved in the regulation of the L-type Ca2+ current in rat ventricular myocytes.
Verde I; Vandecasteele G; Lezoualc'h F; Fischmeister R
Br J Pharmacol; 1999 May; 127(1):65-74. PubMed ID: 10369457
[TBL] [Abstract][Full Text] [Related]
11. Selective blockade of phosphodiesterase types 2, 5 and 9 results in cyclic 3'5' guanosine monophosphate accumulation in retinal pigment epithelium cells.
Diederen RM; La Heij EC; Markerink-van Ittersum M; Kijlstra A; Hendrikse F; de Vente J
Br J Ophthalmol; 2007 Mar; 91(3):379-84. PubMed ID: 16943225
[TBL] [Abstract][Full Text] [Related]
12. Role of multiple cAMP-specific phosphodiesterase variants.
Bushnik T; Conti M
Biochem Soc Trans; 1996 Nov; 24(4):1014-9. PubMed ID: 8968503
[No Abstract] [Full Text] [Related]
13. The effect of Sildenafil on human platelet secretory function is controlled by a complex interplay between phosphodiesterases 2, 3 and 5.
Dunkern TR; Hatzelmann A
Cell Signal; 2005 Mar; 17(3):331-9. PubMed ID: 15567064
[TBL] [Abstract][Full Text] [Related]
14. A reverse-phase HPLC method for cyclic nucleotide phosphodiesterases activity and classification.
Spoto G; Berardi S; Ajerba G; De Laurentiis V
Adv Exp Med Biol; 1994; 370():815-20. PubMed ID: 7661030
[No Abstract] [Full Text] [Related]
15. Phosphodiesterases: the journey towards therapeutics.
Torphy TJ; Page C
Trends Pharmacol Sci; 2000 May; 21(5):157-9. PubMed ID: 10885973
[No Abstract] [Full Text] [Related]
16. Role of phosphodiesterase in cyclic AMP signaling in cultured rat granulosa cells.
Wang Z; Pan L; Luo J; Wang H; Shi F
Reprod Nutr Dev; 2006; 46(2):179-87. PubMed ID: 16597423
[TBL] [Abstract][Full Text] [Related]
17. The N-terminal alternately spliced regions of PDE4A cAMP-specific phosphodiesterases determine intracellular targeting and regulation of catalytic activity.
Houslay MD
Biochem Soc Trans; 1996 Nov; 24(4):980-6. PubMed ID: 8968496
[No Abstract] [Full Text] [Related]
18. Cyclic nucleotide phosphodiesterases: functional implications of multiple isoforms.
Beavo JA
Physiol Rev; 1995 Oct; 75(4):725-48. PubMed ID: 7480160
[TBL] [Abstract][Full Text] [Related]
19. Rabbit corpus cavernosum smooth muscle shows a different phosphodiesterase profile than human corpus cavernosum.
Qiu Y; Kraft P; Lombardi E; Clancy J
J Urol; 2000 Sep; 164(3 Pt 1):882-6. PubMed ID: 10953172
[TBL] [Abstract][Full Text] [Related]
20. cGMP stimulates renin secretion in vivo by inhibiting phosphodiesterase-3.
Beierwaltes WH
Am J Physiol Renal Physiol; 2006 Jun; 290(6):F1376-81. PubMed ID: 16449359
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
